Pharmaceutically active disubstituted triazine derivatives

Abstract

The present invention relates to disubstituted triazine compound, the use of this compound as pharmaceutically active agent, especially for the prophylaxis and / or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine compound. Furthermore, the present invention relates to the use of said disubstituted triazine compound as inhibitor for a protein kinase